Thomas E Starzl

Title: Thomas E. Starzl: A Pioneer in Transplantation Science

Introduction

Thomas E. Starzl is a renowned inventor and medical researcher based in Pittsburgh, PA (US). He has made significant contributions to the field of transplantation, particularly in enhancing the tolerogenicity of grafts. With a total of 8 patents to his name, Starzl's work has paved the way for innovative methods in organ transplantation.

Latest Patents

Among his latest patents, Starzl has developed a composition containing immature mammalian dendritic cells for enhancing tolerogenicity to foreign grafts. This novel transplantation method involves administering immature mammalian dendritic cells, propagated in the presence of a cytokine, to a host mammal prior to transplantation. The method enhances tolerogenicity when these cells concentrate in T-dependent regions of secondary lymphoid tissue, leading to an upregulation of major histocompatibility complex class II antigen. Additionally, he has disclosed a method for regulating dendritic cell maturation, which further enhances the immune response of the host mammal.

Career Highlights

Starzl has had a distinguished career, working with prestigious institutions such as the University of Pittsburgh and Toyobo Co., Ltd. His research has significantly advanced the understanding of immune responses in transplantation, making him a key figure in the field.

Collaborations

Throughout his career, Starzl has collaborated with notable colleagues, including Antonio T. Francavilla and Michio Hagiya. These collaborations have contributed to the development of innovative techniques and methodologies in transplantation science.

Conclusion

Thomas E. Starzl's contributions to transplantation science through his patents and research have had a lasting impact on the field. His innovative approaches continue to influence the way organ transplants are performed and understood today.